DK0973501T3 - Vandig suspension til nasal indgivelse af loteprednol - Google Patents

Vandig suspension til nasal indgivelse af loteprednol

Info

Publication number: DK0973501T3
Authority: DK; Denmark
Prior art keywords: loteprednol; aqueous suspension; nasal administration; nasal; administration
Prior art date: 1997-01-16

Application number

DK98900360T

Other languages

English (en)

Inventor

Koji Doi

Original Assignee

Senju Pharma Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-01-16

Filing date

1998-01-14

Publication date

2004-01-19

1998-01-14 Application filed by Senju Pharma Co filed Critical Senju Pharma Co

2004-01-19 Application granted granted Critical

2004-01-19 Publication of DK0973501T3 publication Critical patent/DK0973501T3/da

Links

239000007900 aqueous suspension Substances 0.000 title 1
YPZVAYHNBBHPTO-MXRBDKCISA-N loteprednol Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)OCCl)[C@@H]4[C@@H]3CCC2=C1 YPZVAYHNBBHPTO-MXRBDKCISA-N 0.000 title 1
229960001798 loteprednol Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Otolaryngology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)

DK98900360T 1997-01-16 1998-01-14 Vandig suspension til nasal indgivelse af loteprednol DK0973501T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP1966497		1997-01-16
PCT/JP1998/000108 WO1998031343A2 (en)	1997-01-16	1998-01-14	Aqueous suspension for nasal administration of loteprednol

Publications (1)

Publication Number	Publication Date
DK0973501T3 true DK0973501T3 (da)	2004-01-19

Family

ID=12005518

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK98900360T DK0973501T3 (da)	1997-01-16	1998-01-14	Vandig suspension til nasal indgivelse af loteprednol

Country Status (32)

Country	Link
US (1)	US6368616B1 (da)
EP (1)	EP0973501B1 (da)
KR (1)	KR100471708B1 (da)
CN (1)	CN1126535C (da)
AR (1)	AR011773A1 (da)
AT (1)	ATE249205T1 (da)
AU (1)	AU730953C (da)
BR (1)	BR9806771A (da)
CA (1)	CA2278025C (da)
CZ (1)	CZ294919B6 (da)
DE (1)	DE69818026T2 (da)
DK (1)	DK0973501T3 (da)
EA (1)	EA001775B1 (da)
ES (1)	ES2206880T3 (da)
HU (1)	HU226613B1 (da)
ID (1)	ID21892A (da)
IL (1)	IL130979A0 (da)
LT (1)	LT4677B (da)
LV (1)	LV12449B (da)
MX (1)	MXPA99006628A (da)
NO (1)	NO324619B1 (da)
NZ (2)	NZ509908A (da)
PL (1)	PL190753B1 (da)
PT (1)	PT973501E (da)
RS (1)	RS49701B (da)
SI (1)	SI20057A (da)
SK (1)	SK283164B6 (da)
TR (1)	TR199901663T2 (da)
TW (1)	TW503113B (da)
UA (1)	UA52722C2 (da)
WO (1)	WO1998031343A2 (da)
ZA (1)	ZA98303B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI243687B (en)	1998-04-21	2005-11-21	Teijin Ltd	Pharmaceutical composition for application to mucosa
AU762145C (en)	1998-08-26	2005-03-17	Teijin Limited	Powdery pernasal compositions
DE19947235A1 (de) *	1999-09-30	2001-04-05	Asta Medica Ag	Neue Kombination von Loteprednol und beta¶2¶-Adrenorezeptor-Agonisten
AR026073A1 (es)	1999-10-20	2002-12-26	Nycomed Gmbh	Composicion farmaceutica acuosa que contiene ciclesonida
US6565832B1 (en) *	2000-01-31	2003-05-20	Schering-Plough Healthcare Products, Inc.	Spray composition with reduced dripping
IL159415A0 (en) *	2001-06-18	2004-06-01	Noven Pharma	Enhanced drug delivery in transdermal systems
GB2389530B (en)	2002-06-14	2007-01-10	Cipla Ltd	Pharmaceutical compositions
US7811606B2 (en) *	2003-04-16	2010-10-12	Dey, L.P.	Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) *	2003-04-16	2014-12-16	Mylan Pharmaceuticals Inc.	Formulations and methods for treating rhinosinusitis
US9808471B2 (en) *	2003-04-16	2017-11-07	Mylan Specialty Lp	Nasal pharmaceutical formulations and methods of using the same
WO2005000317A1 (en)	2003-06-19	2005-01-06	Bodor Nicholas S	Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application
EP1658083B1 (en) *	2003-06-19	2007-08-08	BODOR, Nicholas S.	Enhancement of activity and/or duration of action of selected anti-inflammatory steroids
US20050095205A1 (en) *	2003-10-31	2005-05-05	Ramesh Krishnamoorthy	Combination of loteprednol etabonate and tobramycin for topical ophthalmic use
ATE441419T1 (de)	2004-03-25	2009-09-15	Bausch & Lomb	Verwendung von loteprednoletabonat zur behanldung von trockenen augen
US20070099883A1 (en) *	2005-10-07	2007-05-03	Cheryl Lynn Calis	Anhydrous mometasone furoate formulation
WO2007058935A2 (en) *	2005-11-14	2007-05-24	Bausch & Lomb Incorporated	Ophthalmic composition for dry eye therapy
US7687484B2 (en) *	2006-05-25	2010-03-30	Bodor Nicholas S	Transporter enhanced corticosteroid activity
US7691811B2 (en) *	2006-05-25	2010-04-06	Bodor Nicholas S	Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
WO2012119261A1 (en) *	2011-03-10	2012-09-13	Biocia Inc.	Enhanced artificial mucus composition comprising hyaluronan for the treatment of rhinitis
AU2012312816A1 (en)	2011-09-22	2014-04-24	Bausch & Lomb Incorporated	Ophthalmic gel compositions
HRP20240485T1 (hr)	2017-08-24	2024-07-05	Novo Nordisk A/S	Pripravci glp-1 i njihova upotreba
PE20230819A1 (es)	2020-02-18	2023-05-19	Novo Nordisk As	Composiciones y usos de glp-1

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5540930A (en)	1993-10-25	1996-07-30	Pharmos Corporation	Suspension of loteprednol etabonate for ear, eye, or nose treatment
EP0709099A3 (en)	1994-09-28	1996-07-24	Senju Pharma Co	Aqueous suspension for nasal administration containing cyclodextrin
KR100508227B1 (ko)	1997-03-14	2006-03-23	센주 세이야꾸 가부시키가이샤	로테프레드놀에타보네이트수성현탁액

1998
- 1998-01-06 TW TW087100103A patent/TW503113B/zh not_active IP Right Cessation
- 1998-01-14 AT AT98900360T patent/ATE249205T1/de not_active IP Right Cessation
- 1998-01-14 CA CA002278025A patent/CA2278025C/en not_active Expired - Fee Related
- 1998-01-14 RS YUP-361/99A patent/RS49701B/sr unknown
- 1998-01-14 SI SI9820018A patent/SI20057A/sl not_active IP Right Cessation
- 1998-01-14 CN CN98803402A patent/CN1126535C/zh not_active Expired - Fee Related
- 1998-01-14 IL IL13097998A patent/IL130979A0/xx not_active IP Right Cessation
- 1998-01-14 SK SK948-99A patent/SK283164B6/sk not_active IP Right Cessation
- 1998-01-14 CZ CZ19992374A patent/CZ294919B6/cs not_active IP Right Cessation
- 1998-01-14 NZ NZ509908A patent/NZ509908A/xx unknown
- 1998-01-14 ID IDW990725A patent/ID21892A/id unknown
- 1998-01-14 US US09/341,522 patent/US6368616B1/en not_active Expired - Fee Related
- 1998-01-14 AU AU54952/98A patent/AU730953C/en not_active Ceased
- 1998-01-14 UA UA99084658A patent/UA52722C2/uk unknown
- 1998-01-14 KR KR10-1999-7006440A patent/KR100471708B1/ko not_active Expired - Fee Related
- 1998-01-14 DK DK98900360T patent/DK0973501T3/da active
- 1998-01-14 ZA ZA98303A patent/ZA98303B/xx unknown
- 1998-01-14 BR BR9806771-0A patent/BR9806771A/pt not_active IP Right Cessation
- 1998-01-14 EP EP98900360A patent/EP0973501B1/en not_active Expired - Lifetime
- 1998-01-14 TR TR1999/01663T patent/TR199901663T2/xx unknown
- 1998-01-14 WO PCT/JP1998/000108 patent/WO1998031343A2/en not_active Ceased
- 1998-01-14 NZ NZ336990A patent/NZ336990A/xx unknown
- 1998-01-14 PT PT98900360T patent/PT973501E/pt unknown
- 1998-01-14 MX MXPA99006628A patent/MXPA99006628A/es not_active IP Right Cessation
- 1998-01-14 EA EA199900659A patent/EA001775B1/ru not_active IP Right Cessation
- 1998-01-14 PL PL334614A patent/PL190753B1/pl not_active IP Right Cessation
- 1998-01-14 ES ES98900360T patent/ES2206880T3/es not_active Expired - Lifetime
- 1998-01-14 DE DE69818026T patent/DE69818026T2/de not_active Expired - Fee Related
- 1998-01-14 HU HU0002473A patent/HU226613B1/hu not_active IP Right Cessation
- 1998-01-16 AR ARP980100191A patent/AR011773A1/es active IP Right Grant
1999
- 1999-07-13 NO NO19993453A patent/NO324619B1/no not_active IP Right Cessation
- 1999-07-15 LV LVP-99-109A patent/LV12449B/en unknown
- 1999-08-12 LT LT99-100A patent/LT4677B/lt not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0973501B1 (en)	2003-09-10
CN1126535C (zh)	2003-11-05
UA52722C2 (uk)	2003-01-15
AR011773A1 (es)	2000-09-13
SI20057A (sl)	2000-04-30
TR199901663T2 (xx)	1999-09-21
MXPA99006628A (es)	2005-01-10
ZA98303B (en)	1998-07-20
ATE249205T1 (de)	2003-09-15
IL130979A0 (en)	2001-01-28
NO993453L (no)	1999-07-13
AU730953B2 (en)	2001-03-22
SK94899A3 (en)	2000-05-16
LT4677B (lt)	2000-07-25
AU5495298A (en)	1998-08-07
PT973501E (pt)	2004-02-27
BR9806771A (pt)	2000-05-16
NZ509908A (en)	2004-12-24
EP0973501A2 (en)	2000-01-26
CZ294919B6 (cs)	2005-04-13
EA199900659A1 (ru)	2000-02-28
NZ336990A (en)	2001-03-30
NO324619B1 (no)	2007-11-26
ES2206880T3 (es)	2004-05-16
LT99100A (en)	2000-02-25
HU226613B1 (en)	2009-04-28
CA2278025A1 (en)	1998-07-23
WO1998031343A3 (en)	1998-09-17
YU36199A (sh)	2002-09-19
EA001775B1 (ru)	2001-08-27
KR100471708B1 (ko)	2005-03-07
HUP0002473A3 (en)	2001-01-29
LV12449B (en)	2000-09-20
NO993453D0 (no)	1999-07-13
CN1250370A (zh)	2000-04-12
TW503113B (en)	2002-09-21
PL334614A1 (en)	2000-03-13
DE69818026D1 (de)	2003-10-16
AU730953C (en)	2002-02-07
DE69818026T2 (de)	2004-07-08
SK283164B6 (sk)	2003-03-04
HK1026138A1 (en)	2000-12-08
LV12449A (lv)	2000-04-20
PL190753B1 (pl)	2006-01-31
CA2278025C (en)	2005-09-06
US6368616B1 (en)	2002-04-09
HUP0002473A2 (hu)	2000-12-28
RS49701B (sr)	2007-12-31
ID21892A (id)	1999-08-05
KR20000070214A (ko)	2000-11-25
WO1998031343A2 (en)	1998-07-23
CZ237499A3 (cs)	2000-01-12

Publication	Publication Date	Title
DK0973501T3 (da)	2004-01-19	Vandig suspension til nasal indgivelse af loteprednol
DE69831421D1 (de)	2005-10-06	Zusammensetzungen zur nasalen verabreichung
FR2771012B1 (fr)	2000-03-10	Pulverisateur nasal
DE69624405D1 (de)	2002-11-28	Nasenmaske
NO20003161D0 (no)	2000-06-16	Blandinger for nasal administrasjon av kannabinoider
DE60028845T8 (de)	2007-05-03	Nasale Beatmungsmaske
ID25629A (id)	1999-05-23	AMINA BISIKLIK (Pecahan dari P-961362)
DE69819387D1 (de)	2003-12-11	Kehlkopfmaske
DE69815569D1 (de)	2003-07-24	Kehlkopfmaske
DK1129741T3 (da)	2006-08-07	Forstövningsindretning til inhalator
IS5245A (is)	1999-11-11	Lyfjablanda úr ómeprasól
ATE151622T1 (de)	1997-05-15	Nasaler dilatator
DE69816858D1 (de)	2003-09-04	Beatmungssystem
IT1284049B1 (it)	1998-05-08	Medicamento per somministrazione nasale
NO962103D0 (no)	1996-05-23	Nasal-applikator
IT1295352B1 (it)	1999-05-12	Apparecchio per doccia nasale micronizzata
IS5487A (is)	2000-05-11	Innúðatæki
AU144047S (en)	2001-05-30	Nasal mask
DE69816736D1 (de)	2003-09-04	Nasale Inhaliervorrichtung
NO985936D0 (no)	1998-12-17	Nasal administrasjon av desmopressin
AU144044S (en)	2001-05-30	Nasal mask
ATE289478T1 (de)	2005-03-15	Ektoparasitizide wässrige suspensionsformulierungen von spinosynen
EP0975363A4 (en)	2002-04-17	Attenuated respiratory syncytial virus
DE60021297D1 (de)	2005-08-25	Nasaler Dilatator
EE200300501A (et)	2003-12-15	Ninna manustatavad imidasotriasinooni sisaldavad kompositsioonid